Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Dextran vs Iron Sucrose Safety in Outpatients
NCT00593619Phase 4Suspended
- Sponsor
- London Health Sciences Centre
- Start
- Jan 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of iron dextran in iron deficiency anemia (IDA), sponsored by London Health Sciences Centre. Primary endpoint: Incidence of severe adverse drug reactions. Started Jan 2008; status: suspended.
02
Drugs
iron dextran
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00593619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593619.